en

PRODUCT DETAIL

Uzpruvo 130 mg koncentrát na infúzny roztok

Code 9096E
MA number EU/1/23/1784/005
Product Form: con inf 1x26 ml/130 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: STADA Arzneimittel AG, Germany
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC05 Ustekinumab
Shelf life: 12
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 05.01.2024
Validity: 05.01.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.02.2025
eu-flag.png sk-flag.png